Alzamend Neuro, Inc.: Filed Certificates of Elimination to remove Series B and Series C preferred stock designations from the Certificate of Incorporation (effective 2025-10-14).
Change
charter amendment
Effective
2025-10-14
Exact text from the filing
On October 14, 2025, Alzamend Neuro , Inc., a Delaware corporation (the “ Company ”), filed Certificates of Elimination (collectively, the “ Certificates of Elimination ”) with the Secretary of State of the State of Delaware with respect to the Company’s Series B convertible preferred stock and Series C convertible preferred stock (collectively, the “ Preferred Stock ”), which, effective upon filing, eliminated from the Company’s Certificate of Incorporation, as amended, all matters set forth in the Certificates of Designations for the Preferred Stock.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.